Clinical Trials Directory

Trials / Completed

CompletedNCT01247311

Vitamin D and the Health of Blood Vessels in Kidney Disease

The Impact of Vitamin D Supplementation on Vascular Stiffness and Blood Pressure in Chronic Kidney Disease Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
129 (actual)
Sponsor
University of British Columbia · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

Individuals with kidney disease have a high risk of heart disease. This is not related to traditional risk factors, such as high blood pressure, high cholesterol or being overweight. A lack of vitamin D could be the reason why blood vessels become damaged and could explain the link between heart disease and kidney disease.

Detailed description

Most people living in Canada do not receive enough vitamin D from the sun or from the food they eat. When a person has kidney disease this is a particular problem as kidney disease stops what little vitamin D we do have being activated in the body. Low levels of activated vitamin D causes a domino effect with calcium and phosphate and all the hormones that control calcium and phosphate. Some people believe that this imbalance damages the blood vessels causing them to become stiff and inflexible (arterial stiffness) and this in turn could cause heart disease. In addition there are two different types of vitamin D that can be prescribed and it is currently not known whether there is any difference between the two types of vitamin D and the effect they have on the blood vessels. The purpose of this study is to investigate whether providing vitamin D as a medication can have a direct affect on the stiffness of the blood vessels. The findings of this study will help both physicians and dietitians decide whether Vitamin D therapy is beneficial to patients and should help decide which type of Vitamin D is best to give to people with chronic kidney disease (CKD).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTDietary supplementPlacebo given orally 3xweek for six months
DIETARY_SUPPLEMENTVitamin D5000 IU vitamin D given orally 3xweek for six months
DIETARY_SUPPLEMENTVitamin D0.5ug 1,25 vitamin D given orally 3xweek for six months

Timeline

Start date
2010-11-01
Primary completion
2014-08-01
Completion
2014-08-01
First posted
2010-11-24
Last updated
2017-06-15

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01247311. Inclusion in this directory is not an endorsement.